Roche Hldg Acciones Foro

Hello folks

What do you think about buying shares? I think everyone knows that as soon as you have found a suitable share for your portfolio and bought it, the price falls.

The price of Roche is now below the 5-year chart. However, as I have never bought a share before, I wanted to ask whether it makes sense to buy additional shares if you believe in the company in the long term? The second purchase would also result in additional fees.

The cancellation of the repurchased bearer shares increases the free float from currently 16.6% to 24.9% and allows Roche to be listed in the Swiss Performance Index (SPI) and other indices.

The U.S. government will purchase an additional 1.4 million doses of Regeneron's Corona virus antibody cocktail. At a price of $2,100 per dose, this represents a volume of $2.94 billion.

https://markets.businessinsider.com/news/stocks/regeneron-announces-new-u-s-government-agreement-to-purchase-additional-doses-of-regen-cov-casirivimab-and-imdevimab-antibody-cocktail-1030799885

Falls below horizontal support and EMA 50

Another positive step towards cure / mitigation of Alzheimer's disease.

AC Immune announced today in a company release that one of the primary objectives of the Phase 2 trial with partner Genentech (Roche Group) has been met.

AC Immune's stock is up 70% as a result.

Announcement from AC Immune:

https://ir.acimmune.com/news-releases/news-release-details/ac-immune-announces-first-positive-cognitive-results-tau
$IMR (-3,03 %)
$RHO (-1,37 %)

The team of Fierce Pharma has analyzed data of the 11 largest pharmaceutical companies and evaluated which company generates the most sales with new (in the last 5 years brought to market) drugs and this also related to the total sales (drugs).

I find this extremely interesting, as drug sales completely collapse once the patent expires and cheap generics enter the market.

In this regard, it is good to know that companies with current drugs are well positioned for the coming years.

Here is the full article:

https://www.fiercepharma.com/special-report/who-s-getting-most-out-their-r-d-engine-pharma-s-top-11-ranked

Japan approves Roche and Regeneron drug to treat COVID patients. $RHO (-1,37 %)
$RGO (-0,45 %)

Source: https://www.google.de/amp/s/www.nau.ch/amp/news/ausland/coronavirus-japan-lasst-medikamentencocktail-von-roche-zu-65967771

How important is sustainability and social responsibility to you when investing? 🌎

The MSCI World Socially Responsible Index is based on its big brother the MSCI World, but without nuclear power, coal, alcohol, tobacco, gambling, weapons and genetic engineering.

The largest positions are currently Microsoft, Tesla, Nvidia, Home Depot, and Walt Diney.

From Europe, ASML and Roche make it into the top ten.

$MSF (+1,59 %)
$TL0 (-6,59 %)
$NVD (+2,32 %)
$HDI (-1,24 %)
$WDP (+0,59 %)
$RHO (-1,37 %)
$ASME (+0,06 %)

The 50 most profitable companies in the world.